EMAIL THIS PAGE TO A FRIEND

Journal of biomedical nanotechnology

A comparison of TiO2 and ZnO nanoparticles as photosensitizers in photodynamic therapy for cancer.


PMID 25016645

Abstract

The TiO2 and ZnO nanoparticles are the most promising next-generation photodynamic therapy (PDT) photosensitizers. This paper reports a one-to-one comparison of TiO2 and ZnO nanoparticles as photosensitizers in photodynamic therapy of cancer. After incubating SMMC-7721 hepatocarcinoma cells with TiO2 and ZnO nanoparticles, we irradiated the cells with ultraviolet (UV) light and formation of intracellular reactive oxygen species (ROS) was monitored using the dichloro-dihydro-fluorescein diacetate (DCFH-DA) method. The cytotoxicities of ZnO and TiO2 nanoparticles as photosensitizers in cancer PDT were evaluated using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Furthermore, the mRNA and protein expression levels of apoptosis-related gene, including Bax, Bcl-2, and Caspase 3 were examined using RT-PCR and Western blot to elucidate the possible molecular mechanisms involved. Our results demonstrated that both TiO2 and ZnO nanoparticles could generate ROS within the tumor cells after irradiation, which in turn could attack the cancer cells. The caspase-dependent apoptosis was thus induced, resulting in anticancer activity. When the therapeutic effects were compared, no differences between the TiO2 and ZnO nanoparticles were observed for PDT. Either TiO2 or ZnO nanoparticles can therefore be used in the near future as alternative photosensitizers in targeted tumor PDT when light is directly focused on the lesion.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

14027
Titanium(IV) oxide, puriss., meets analytical specification of Ph. Eur., BP, USP, 99-100.5%
O2Ti
14021
Titanium(IV) oxide, ReagentPlus®, ≥99%
O2Ti
96479
Zinc oxide, puriss. p.a., ACS reagent, ≥99.0% (KT)
OZn
14439
Zinc oxide, puriss., meets analytical specification of Ph. Eur., BP, USP, 99-100.5% (calc. for dried substance)
OZn
96492
Zinc oxide, tested according to Ph.Eur.
OZn
93632
Zinc oxide, analytical standard
OZn
204951
Zinc oxide, 99.999% trace metals basis
OZn
255750
Zinc oxide, 99.99% trace metals basis
OZn
205532
Zinc oxide, ReagentPlus®, powder, <5 μm particle size, 99.9%
OZn
544906
Zinc oxide, nanopowder, <100 nm particle size
OZn
677450
Zinc oxide, nanopowder, <50 nm particle size (BET), >97%
OZn
752681
Zinc oxide, sputtering target, diam. × thickness 3.00 in. × 0.125 in., 99.99% trace metals basis
OZn
773999
Zinc oxide, nanowires, diam. × L 90 nm × 1 μm
OZn
773980
Zinc oxide, nanowires, diam. × L 50 nm × 300 nm
OZn
774006
Zinc oxide, nanowires, diam. × L 300 nm × 4-5 μm
OZn
721077
Zinc oxide, dispersion, nanoparticles, <100 nm particle size (TEM), ≤40 nm avg. part. size (APS), 20 wt. % in H2O
721085
Zinc oxide, dispersion, nanoparticles, 40 wt. % in ethanol, <130 nm particle size
721093
Zinc oxide, dispersion, nanoparticles, <110 nm particle size, 40 wt. % in butyl acetate